製药和生物技术製造与供应贸易：2020-2025

《製药和生物技术领域的製造和供应交易》提供了对公司如何以及为何达成製造和供应交易的深入了解和分析。这份经过全面修订和更新的报告提供了 2019 年至 2025 年的详细製造和供应交易。

此报告提供双方宣布的製造和供应交易的付款条款。这些数据为付款条款和其他贸易条款提供了有用的见解。

了解潜在合作伙伴谈判交易条款的弹性可以为谈判过程提供重要的见解，让您了解谈判条款时会发生什么。许多中小企业可能会要求详细的付款条款，但细节决定成败，例如如何发起付款以及如何转让权利。

本报告提供了当前协议交易和合作伙伴关係资料库中记录的自 2020 年以来宣布的製造和供应交易的综合列表，包括可用的财务条款，以及公司及其合作伙伴向美国证券交易委员会提交的实际製造和供应交易文件的在线副本链接。

报告的第一章介绍了製造和供应交易和商业活动。

第 1 章对报告进行了介绍，第 2 章概述并分析了製造和供应趋势，并讨论了各种贸易类型的优点。

第 3 章概述了製造和供应交易的结构。

第 4 章回顾了 2020 年及以后的主要製造和供应机会。交易按价值列出。对于已向美国证券交易委员会公开披露协议的案件，您可以透过这些连结透过目前协议交易和联盟资料库在线存取这些协议。

第 5 章提供了最活跃的 25 家製造和供应贸易公司的综合清单。每个交易标题都透过当前协议的交易和联盟资料库连结到完整交易记录的线上版本，并在可用时连结到实际合约文件，从而可以轻鬆按需存取每个交易记录。

第 6 章全面详细地回顾了自 2020 年以来达成或宣布的製造和供应交易，其中提供了合约文件，按公司 A-Z、治疗领域、技术和行业垂直顺序排列。合约文件详细介绍了双方就製造和供应交易达成的实际条款和条件。

交易目录包含自 2019 年以来宣布的所有製造和供应交易的综合清单。每个清单都按公司 A-Z、治疗领域和技术类型组织为贸易目录。每个交易标题都透过超连结连结到交易记录的线上版本，包括实际的合约文件（如果有）。

该报告还包含大量图表和图形，重点介绍 2020 年及以后的製造和供应交易趋势和活动。

目录

摘要整理

第1章 简介

第2章 製造业和供应链趋势

• 简介
• 製造·供给交易定义
• 2020年以后的製造·供给交易趋势
  • 製造·供给交易的各年度转变，2020年～2025年
  • 各开发阶段的製造·供给交易，2020年～2025年
  • 各产业部门的製造·供给交易，2020年～2025年
  • 各治疗领域的製造·供给交易，2020年～2025年
  • 各技术类型的製造·供给交易，2020年～2025年
  • 最活跃的各企业製造·供给交易，2020年～2025年
• 为什么要签订製造和供应合作协议？
• 製造与供应链交易的未来

第3章 製造·供给交易结构概要

• 简介
• 製造及供给交易结构

第4章 主要製造·供给交易

• 简介
• 各金额首位製造·供给交易

第5章 最活跃的製造·供给交易厂商前几名25公司

• 简介
• 最活跃的製造·供给交易厂商前几名25公司

第6章 含契约名录的製造·供给交易

• 简介
• 按2020年～2025年的交易的製造·供给交易
• 交易名录
• 行业名录 - 製造和供应行业（按公司划分）(AZ)
• 贸易目录 - 按治疗领域划分的製造和供应交易
• 行业名录 - 按技术类型划分的製造和供应行业
• 关于调查公司
• 目前联盟
• 目前契约
• Current 来自Partnering的最近的报告标题

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter manufacturing and supply deals.

Fully revised and updated, the report provides details of manufacturing and supply deals from 2019 to 2025.

The report provides access to manufacturing and supply deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of manufacturing and supply deals announced since 2020 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual manufacturing and supply contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of manufacturing and supply dealmaking and business activities.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in manufacturing and supply as well as a discussion on the merits of the type of deal.

Chapter 3 provides an overview of the structure of manufacturing and supply deals.

Chapter 4 provides a review of the leading manufacturing and supply deals since 2020. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive listing of the top 25 most active manufacturing and supply dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.

Chapter 6 provides a comprehensive and detailed review of manufacturing and supply deals organized by company A-Z, therapy, technology and industry type signed and announced since 2020 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the manufacturing and supply deal.

The deal directory includes a comprehensive listing of all manufacturing and supply deals announced since 2019. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report also includes numerous table and figures that illustrate the trends and activities in manufacturing and supply dealmaking since 2020.

In conclusion, this report provides everything a prospective dealmaker needs to know about manufacturing and supply alliances.

Key benefits

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology provides the reader with the following key benefits:

• Understand deal trends since 2020
• Browse manufacturing and supply deals
• Benchmark analysis - identify market value of transactions
• Financials terms
• Directory of deals by company A-Z, therapy focus and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Report scope

• Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology is intended to provide the reader with an in-depth understanding of the manufacturing and supply trends and structure of deals entered into by leading biopharma companies worldwide.

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology includes:

• Trends in manufacturing and supply dealmaking in the biopharma industry
• Overview of manufacturing and supply deal structure
• Directory of manufacturing and supply deal records covering pharmaceutical and biotechnology
• The leading manufacturing and supply deals by value
• Most active manufacturing and supply dealmakers
• The leading manufacturing and supply partnering resources

In Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology, the available deals are listed by:

• Company A-Z
• Headline value
• Therapeutic area
• Technology type
• Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.
• Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology provides comprehensive access to available records for manufacturing and supply deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

• What are the rights granted or optioned?
• What rights are granted by the agreement?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are intellectual property rights handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in manufacturing and supply dealmaking

• 2.1. Introduction
• 2.2. Definition of manufacturing and supply deal
• 2.3. Trends in manufacturing and supply deals since 2020
  • 2.3.1. Manufacturing and supply dealmaking by year, 2020-2025
  • 2.3.2. manufacturing and supply dealmaking by phase of development, 2020-2025
  • 2.3.3. Manufacturing and supply dealmaking by industry sector, 2020-2025
  • 2.3.4. Manufacturing and supply dealmaking by therapy area, 2020-2025
  • 2.3.5. Manufacturing and supply dealmaking by technology type, 2020-2025
  • 2.3.6. Manufacturing and supply dealmaking by most active company, 2020-2025
• 2.4. Reasons for entering into manufacturing and supply partnering deals
• 2.5. The future of manufacturing and supply deals

Chapter 3 - Overview of manufacturing and supply deal structure

• 3.1. Introduction
• 3.2. manufacturing and supply agreement structure

Chapter 4 - Leading manufacturing and supply deals

• 4.1. Introduction
• 4.2. Top manufacturing and supply deals by value

Chapter 5 - Top 25 most active manufacturing and supply dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active manufacturing and supply dealmakers

Chapter 6 - manufacturing and supply deals including contracts directory

• 6.1. Introduction
• 6.2. manufacturing and supply deals with contracts 2020-2025
• Deal directory
• Deal directory - manufacturing and supply dealmaking by companies A-Z
• Deal directory - manufacturing and supply dealmaking by therapy area
• Deal directory - manufacturing and supply dealmaking by technology type
• About Biopharma Research
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of manufacturing and supply
• Figure 2: Trends in manufacturing and supply deal announcements, 2020-2025
• Figure 3: Manufacturing and supply deals signed at each phase of development, 2020-2025
• Figure 4: Manufacturing and supply deals by industry sector, 2020-2025
• Figure 5: Manufacturing and supply deals by therapy area, 2020-2025
• Figure 6: Manufacturing and supply deals by technology type, 2020-2025
• Figure 7: Top 25 most active manufacturing and supply dealmakers, 2020-2025
• Figure 8: Top manufacturing and supply deals by value, 2020-2025
• Figure 9: Most active manufacturing and supply dealmakers, 2020-2025